The latest news:

ImmuDyne Announces Publication of New Cancer Study
Wednesday December 10, 1:12 pm ET

FLORENCE, Ky., Dec. 10, 2008 (GLOBE NEWSWIRE) -- ImmuDyne (Other OTC:IMMD.PK - News), the leading supplier of Yeast Beta Glucan, announced today a new study, submitted by Dr. Alan B. Weitberg, has been published in the Journal of Experimental & Clinical Cancer Research:

http://www.jeccr.com/content/27/1/40
Download in pdf format Cancer_Research_D-glucan.pdf

ImmuDyne provided certain patented, proprietary product throughout the conducting of this study.

About Immudyne^®